/channels/news_feeds/all/term/CIMTEC/rss en /channels/news/kalgene-gears-manufacture-and-test-promising-alzheimer%E2%80%99s-treatment-nrc-mcgill-and-cimtec-263196 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><div> <div> <div> <p>KalGene Pharmaceuticals and the National Research Council of Canada (NRC) are proud to announce the signature of an agreement worth over $1M to develop, scale up, and transfer the technology needed to manufacture a promising novel Alzheimer鈥檚 treatment in Canada that the parties have been co- developing since 2015.</p> <p>The treatment, a biologic molecule made up of a peptide that fights Alzheimer鈥檚 and an antibody-based carrier molecule designed to shuttle the peptide into the brain, is a custom- engineered therapeutic developed at NRC.</p></div></div></div></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">3 </span><span class="month">October </span><span class="year">2016</span></div></div></div></div></div> Mon, 03 Oct 2016 18:55:49 +0000 webfull 121769 at /channels